House Bill 317

Actions | Amendments
Last Action 2nd reading, to Rules
Title AN ACT relating to health care services provided in clinical trials for the treatment of cancer.
Bill Documents Bill
Bill Request Number 1241
Sponsors M. Marzian, M. Dedman Jr., C. Hoffman, J. Jenkins
Summary of Original Version Create a new section of Subtitle 17A of KRS Chapter 304 to require a health benefit plan to cover health care services for the treatment of cancer in a clinical trial if those services would be covered if not provided in a clinical trial; require clinical trials to meet therapeutic criteria and be approved by appropriate agencies; provide that this coverage is not a health benefit mandate.
Index Headings of Original Version Diseases - Cancer, clinical trials for treatment of, health plan coverage of
Drugs and Medicines - Cancer, clinical trials for treatment of, health plan coverage of
Health and Medical Services - Cancer, clinical trials for treatment of, health plan coverage of
Insurance, Health - Cancer, clinical trials for treatment of, health plan coverage of
Physicians and Practitioners - Cancer, clinical trials for treatment of, health plan coverage of
Proposed Amendments House Committee Substitute 1
House Floor Amendment 1
House Floor Amendment 2
Votes Vote History

Actions

Top | Amendments
01/16/08
  • introduced in House
01/17/08
  • to Banking & Insurance (H)
01/24/08
  • posted in committee
02/13/08
  • reported favorably, 1st reading, to Calendar with Committee Substitute
02/14/08
  • 2nd reading, to Rules
02/15/08
  • floor amendments (1) and (2) filed to Committee Substitute
02/19/08
  • posted for passage in the Regular Orders of the Day for Wednesday, February 20, 2008
03/04/08
  • 3rd reading, passed 97-0 with Committee Substitute, floor amendment (2)
03/05/08
  • received in Senate
03/07/08
  • to Banking & Insurance (S)
03/25/08
  • reported favorably, 1st reading, to Consent Calendar
03/26/08
  • 2nd reading, to Rules

Proposed Amendments

Top | Actions
Amendment House Committee Substitute 1
Summary Create a new section of Subtitle 17A of KRS Chapter 304 to prohibit a health benefit plan from excluding coverage for routine patient healthcare costs that are incurred in the course of a cancer clinical trial if the health benefit plan would provide coverage for the routine patient healthcare cost had it not been incurred in a cancer clinical trial; provide that nothing in this section requires a policy to offer, nor prohibits a policy from offering, cancer clinical trial services by a participating provider; provide that nothing in this section requires services that are performed in a cancer clinical trial by a nonparticipating provider of a policy to be reimbursed at the same rate as a participating provider of the policy.
Index Headings Diseases - Cancer, clinical trials for treatment of, health plan coverage of
Drugs and Medicines - Cancer, clinical trials for treatment of, health plan coverage of
Health and Medical Services - Cancer, clinical trials for treatment of, health plan coverage of
Insurance, Health - Cancer, clinical trials for treatment of, health plan coverage of
Physicians and Practitioners - Cancer, clinical trials for treatment of, health plan coverage of

Amendment House Floor Amendment 1
Sponsor M. Marzian
Summary Retain original provisions except delete language in definition of "cancer clinical trial" referencing "Phase III clinical trial"; insert language requiring that the cancer clinical trial be approved by the National Institutes of Health, or any institutional review board recognized by the National Institutes of Health, The United States Food and Drug Administration, The United States Department of Defense, or The United States Veterans Administration.
Index Headings Diseases - Cancer, clinical trials for treatment of, health plan coverage of
Drugs and Medicines - Cancer, clinical trials for treatment of, health plan coverage of
Health and Medical Services - Cancer, clinical trials for treatment of, health plan coverage of
Insurance, Health - Cancer, clinical trials for treatment of, health plan coverage of
Physicians and Practitioners - Cancer, clinical trials for treatment of, health plan coverage of

Amendment House Floor Amendment 2
Sponsor M. Marzian
Summary Retain original provisions except delete language in definition of "cancer clinical trial" referencing "Phase III clinical trial"; insert language requiring that the cancer clinical trial be approved by the National Institutes of Health, or any institutional review board recognized by the National Institutes of Health, The United States Food and Drug Administration, The United States Department of Defense, or The United States Veterans Administration, delete language defining "routine patient healthcare costs"; insert language redefining "routine patient healthcare costs" to mean all healthcare services, items, and drugs for the treatment of cancer.
Index Headings Diseases - Cancer, clinical trials for treatment of, health plan coverage of
Drugs and Medicines - Cancer, clinical trials for treatment of, health plan coverage of
Health and Medical Services - Cancer, clinical trials for treatment of, health plan coverage of
Insurance, Health - Cancer, clinical trials for treatment of, health plan coverage of
Physicians and Practitioners - Cancer, clinical trials for treatment of, health plan coverage of

Last updated: 1/16/2019 5:01 PM (EST)